← Back to Search

Wound Closure Methods for Scar Appearance

N/A
Waitlist Available
Led By Daniel Eisen, MD
Research Sponsored by University of California, Davis
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
18 years of age or older
Patient scheduled for cutaneous surgical procedure on the head, neck, trunk, or extremities with predicted purse-string closure
Must not have
Under 18 years of age
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 3 months
Awards & highlights

Summary

This trial aims to compare two different methods of closing wounds to see which one results in better-looking scars and fewer complications. They will close half of the wound with one method and the other half with another

Who is the study for?
This trial is for individuals with scars who are undergoing surgery that requires wound closure. The study will compare two different stitching techniques to see which results in better-looking scars and fewer complications.
What is being tested?
The study tests intra-dermal versus transcutaneous purse-string closures on wounds. Each patient's wound is split; one half gets the intra-dermal method, the other half gets the transcutaneous method. Scar appearance and any complications are assessed after three months.
What are the potential side effects?
Potential side effects may include differences in scar appearance, discomfort at the suture site, infection, or other common post-surgical complications related to wound healing.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am 18 years old or older.
Select...
I am scheduled for skin surgery with a specific type of closure.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I am under 18 years old.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~3 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 3 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Observer Scar Assessment as measured by Patient Observer Scar Assessment Score (POSAS)
Secondary outcome measures
Complications or Adverse Events from Treatment
Patient Scar Assessment as measured by Patient Observer Scar Assessment Score (POSAS)
Width of Scar as measured using Trace-to-Tape Method

Trial Design

2Treatment groups
Experimental Treatment
Group I: Intra-dermal purse-string closure on Side BExperimental Treatment2 Interventions
For all participants, one wound side half will be labeled as A and the other side as B. Side B will be closed with a intra-dermal purse-string closure, and Side A will be closed with a transcutaneous purse-string closure.
Group II: Intra-dermal purse-string closure on Side AExperimental Treatment2 Interventions
For all participants, one wound side half will be labeled as A and the other side as B. Side A will be closed with a intra-dermal purse-string closure, and Side B will be closed with a transcutaneous purse-string closure.

Find a Location

Who is running the clinical trial?

University of California, DavisLead Sponsor
919 Previous Clinical Trials
4,720,819 Total Patients Enrolled
9 Trials studying Scarring
433 Patients Enrolled for Scarring
Daniel Eisen, MDPrincipal InvestigatorUniversity of California, Davis - Dermatology
10 Previous Clinical Trials
554 Total Patients Enrolled
5 Trials studying Scarring
250 Patients Enrolled for Scarring
~49 spots leftby Jul 2026
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top